By combining GLP-1, GIP, and glucagon receptor activity, these therapies may enhance appetite suppression, improve insulin sensitivity, and increase energy expenditure
Weight regain after stopping GLP-1 medications is the rule, not the exception
La carnitina tambin se une a grupos acetilo y previene la acumulacin de acetil-CoA, lo que se sugiere que ayuda con el ejercicio de alta intensidad
Headaches associated with GLP-1 therapy are typically most common during the initial weeks of treatment or following dose escalation
By understanding the causes and applying a combination of dietary, lifestyle, and medical strategies, you can significantly reduce nausea and continue to reap the benefits of these powerful medications
Patients should aim to stay active, maintain a healthy weight, and avoid prolonged periods of immobility